A chemical toolbox for the study of bromodomains and epigenetic signaling

A chemical toolbox for the study of bromodomains and epigenetic signaling

Bromodomains are conserved protein interaction modules that recognize acetyl-lysine modifications. Here the authors present a set of 25 selective small molecule inhibitors covering 29 human bromodomain targets and comprehensively evaluate the selectivity of this probe-set.

Bibliographic Details
Main Authors:	Qin Wu, David Heidenreich, Stanley Zhou, Suzanne Ackloo, Andreas Krämer, Kiran Nakka, Evelyne Lima-Fernandes, Genevieve Deblois, Shili Duan, Ravi N. Vellanki, Fengling Li, Masoud Vedadi, Jeffrey Dilworth, Mathieu Lupien, Paul E. Brennan, Cheryl H. Arrowsmith, Susanne Müller, Oleg Fedorov, Panagis Filippakopoulos, Stefan Knapp
Format:	Article
Language:	English
Published:	Nature Portfolio 2019-04-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-019-09672-2

Similar Items

A chemical toolbox for the study of bromodomains and epigenetic signaling
by: Wu, Q, et al.
Published: (2019)

The bromodomain interaction module.
by: Filippakopoulos, P, et al.
Published: (2012)

The bromodomain interaction module
by: Filippakopoulos, P, et al.
Published: (2012)

Bromodomains as therapeutic targets.
by: Muller, S, et al.
Published: (2011)

Targeting bromodomains: epigenetic readers of lysine acetylation.
by: Filippakopoulos, P, et al.
Published: (2014)

Developing chemical probes for the BET bromodomains
by: Hewings, D, et al.
Published: (2012)

Developing small molecule inhibitors of the CREBBP bromodomain-histone interaction
by: Rooney, T, et al.
Published: (2012)

The design and synthesis of 5-and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains
by: Hay, D, et al.
Published: (2013)

Chemical probes for bromodomains outside the BET family
by: Brennan, P, et al.
Published: (2013)

3,5-Dimethylisoxazoles inhibit the bromodomain-histone protein-protein interaction
by: Hewings, D, et al.
Published: (2012)

Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family.
by: Filippakopoulos, P, et al.
Published: (2012)

Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family
by: Filippakopoulos, P, et al.
Published: (2012)

Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery.
by: Philpott, M, et al.
Published: (2011)

Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery.
by: Philpott, M, et al.
Published: (2011)

Histone recognition and large-scale structural analysis of the human bromodomain family.
by: Filippakopoulos, P, et al.
Published: (2012)

Small-molecule bromodomain inhibitors for cancer therapy
by: Qi, J, et al.
Published: (2010)

RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.
by: Picaud, S, et al.
Published: (2013)

RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain
by: Picaud, S, et al.
Published: (2013)

Development of selective CBP/P300 benzoxazepine bromodomain inhibitors
by: Popp, T, et al.
Published: (2016)

3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.
by: Hewings, D, et al.
Published: (2011)

Stimulation of Hepatic Apolipoprotein A-I Production by Novel Thieno-Triazolodiazepines: Roles of the Classical Benzodiazepine Receptor, PAF Receptor, and Bromodomain Binding.
by: Kempen, H, et al.
Published: (2013)

Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.
by: Hewings, D, et al.
Published: (2013)

Selective targeting of bromodomains of the bromodomain-PHD fingers family impairs osteoclast differentiation
by: Meier, JC, et al.
Published: (2017)

[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.
by: Fedorov, O, et al.
Published: (2014)

Functions of bromodomain-containing proteins and their roles in homeostasis and cancer
by: Fujisawa, T, et al.
Published: (2017)

3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands
by: Hewings, D, et al.
Published: (2011)

Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.
by: Ciceri, P, et al.
Published: (2014)

Emerging tools to investigate bromodomain functions
by: Kougnassoukou Tchara, P, et al.
Published: (2019)

Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
by: Hay, D, et al.
Published: (2014)

Selective inhibition of BET bromodomains.
by: Filippakopoulos, P, et al.
Published: (2010)

Selective inhibition of BET bromodomains.
by: Filippakopoulos, P, et al.
Published: (2010)

Corrigendum: Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.
by: Ciceri, P, et al.
Published: (2014)

PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.
by: Picaud, S, et al.
Published: (2013)

Molecular basis of histone tail recognition by human TIP5 PHD finger and bromodomain of the chromatin remodeling complex NoRC.
by: Tallant, C, et al.
Published: (2015)

Bromodomains control amyloid-like aggregation of aberrantly acetylated proteins
by: Olzscha, H, et al.
Published: (2018)

Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain.
by: Ferguson, F, et al.
Published: (2013)

A chemical biology toolbox to study protein methyltransferases and epigenetic signaling
by: Sebastian Scheer, et al.
Published: (2019-01-01)

Structure-based approaches towards identification of fragments for the low-druggability ATAD2 bromodomain
by: Chaikuad, A, et al.
Published: (2014)

A series of potent CREBBP bromodomain ligands reveals an induced-fit pocket stabilized by a cation-π interaction
by: Rooney, T, et al.
Published: (2014)

Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance.
by: Fedorov, O, et al.
Published: (2015)